New device aims to boost circulation and ward off dangerous clots

NCT ID NCT05511064

Completed Disease control Sponsor: Ceragem Clinical Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed trial tested a device called CGM MB-1701 to see if it can improve blood flow in people at risk for deep vein thrombosis (DVT). The study enrolled 60 adults who did not have DVT at the start. Researchers measured changes in blood flow speed in the leg vein after using the device for 5 and 10 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CGM MB-1701 blood circulation device
What this could lead to: If it works, this device could help prevent dangerous blood clots in people at risk for deep vein thrombosis.
What could go wrong: This is a small, early-stage trial with only 60 participants. The device may not prove effective or safe in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD CIRCULATION DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vascular disorder venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CIRCULATION DISORDER DEEP VEIN THROMBOSIS

Contacts and locations

Locations

Korea University Guro Hospital

Seoul, South Korea
Presbyterian Medical Center

Jeonju, South Korea
Seoul National University Bundang Hospital

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.